Home

Results 41 - 50 of 262,042 for essentially. Search took 2.774 seconds.  
Sort by date/Sort by relevance
Essential Interventions FAQ SUMMARY ESSENTIAL INTERVENTIONS, COMMODITIES AND GUIDELINES for Reproductive, Maternal, Newborn and Child Health WHAT IS ESSENTIAL INTERVENTIONS, COMMODITIES AND GUIDELINES FOR REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH? (...) WHY WAS ESSENTIAL INTERVENTIONS, COMMODITIES AND GUIDELINES FOR REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH WRITTEN? (...) Many of these deaths could be avoided through the provision of essential interventions along the continuum of care.
Language:English
Score: 517241.16 - https://www.who.int/pmnch/topi...ntial_interventions_faq_en.pdf
Data Source: un
Select language Select language English Western Pacific Home Health topics All health topics » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Popular topics >> COVID-19 Ageing Vaccines Universal Health Coverage Mental health Tobacco Antimicrobial resistance Climate change Featured topic >> Primary health care WHO/Yoshi Shimizu © Credits Our work Universal health coverage >> Healthy environments and populations >> Health security and emergencies >> Disease elimination and control >> Year of the Nurse and Midwife >> Resources >> Publications Library Data Regional data>> Regional COVID-19 dashboard Newsroom All news >> News releases Feature stories Commentaries Speeches Events Headlines >> Multimedia >> Photos Videos Infographics Featured story >> Emergencies Outbreaks and emergencies >> Coronavirus disease (COVID-19) Polio in Malaysia Polio outbreak in the Philippines Surveillance >> Influenza Avian influenza Dengue Emergency advice >> Pacific islands surveillance >> COVID-19 in the Region >> Getty images © Credits About us Overview >> How we work Where we work Programmes Country support Pacific Technical Support Governance >> Regional Director Regional Committee Working for Better Health in the Western Pacific >> Partnerships >> Collaborating Centers Donors Regional health initiatives Careers >> Contact us >> RCM 2022 >> Home / Health topics / Essential medicines Essential medicines Essential medicines in the Western Pacific Essential medicines are those that satisfy the priority health care needs of the population. (...) The increasing need for essential medicines due to the growing burden of diseases is stretching country pharmaceutical systems and budgets. (...) Technical links Fact sheets Prequalification of medicines by WHO Substandard and falsified medical products Universal health coverage (UHC) Data Essential medicines Priority health technologies Western Pacific Health Data Platform on Essential Medicines WHO resolutions Addressing the global shortage of, and access to, medicines and vaccines, Report by the Director-General (A71/12) WHO/Yoshi Shimizu © Credits 14.11 14.11 Public spending on medicines per person per year (2007), US$ in Lower income countries   WHO/Yoshi Shimizu © Credits 18 countries and territories 18 countries and territories have a National Medicines Policy in Place in the Western Pacific Region   WHO/Yoshi Shimizu © Credits 20.41 20.41 Public spending on medicines per person per year (2007), US$ in Middle-income countries   - Our work Strengthening health purchasing Tackling antimicrobial resistance Improving access to essential medicines Working towards universal health coverage Featured publications All → 31 January 2018 How pharmaceutical systems are organized in Asia and the Pacific Download Read More 24 August 2017 Towards access 2030: WHO essential medicines and health products strategic framework 2016-2030 Download Read More 14 June 2016 Universal health coverage : moving towards better health : action framework for the Western Pacific Region Download Read More News All → 13 October 2016 News release WHO Regional Committee for the Western Pacific notes progress on healthy newborn infants, antimicrobial resistance and essential medicines 16 April 2016 News release Asia Pacific countries vow to tackle antimicrobial resistance together 15 October 2015 News release La soixante-sixième session du Comité régional de l’OMS salue les progrès accomplis dans les domaines du vieillissement et de la santé, de la prévention et de la maîtrise des maladies non transmissibles, et du renforcement des systèmes de réglementation Multimedia 11 November 2021 Making medicines and the health workforce safer Related links Global programme on essential medicines and health products WHO Selection of essential medicines   Resources WHO Model Lists of Essential Medicines WHO Essential Medicines Teaching Resources PIEMEDS - Price Information Exchange for Medicines Sign in: Med Quality Assurance Related Health Topics All → Communicable diseases HIV Other Universal health coverage Health interventions Vaccines 1 (current) 2 3 Quick links Newsroom Emergencies Data Campaigns Publications About us Overview Programmes Country support Governance Partnerships Help Contact us Press Careers Email scams Privacy Legal Notice © 2022 WHO
Language:English
Score: 517241.16 - https://www.who.int/westernpac...lth-topics/essential-medicines
Data Source: un
Select language Select language English Western Pacific Home Health topics All health topics » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Popular topics >> COVID-19 Ageing Vaccines Universal Health Coverage Mental health Tobacco Antimicrobial resistance Climate change Featured topic >> Primary health care WHO/Yoshi Shimizu © Credits Our work Universal health coverage >> Healthy environments and populations >> Health security and emergencies >> Disease elimination and control >> Year of the Nurse and Midwife >> Resources >> Publications Library Data Regional data>> Regional COVID-19 dashboard Newsroom All news >> News releases Feature stories Commentaries Speeches Events Headlines >> Multimedia >> Photos Videos Infographics Featured story >> Emergencies Outbreaks and emergencies >> Coronavirus disease (COVID-19) Polio in Malaysia Polio outbreak in the Philippines Surveillance >> Influenza Avian influenza Dengue Emergency advice >> Pacific islands surveillance >> COVID-19 in the Region >> Getty images © Credits About us Overview >> How we work Where we work Programmes Country support Pacific Technical Support Governance >> Regional Director Regional Committee Working for Better Health in the Western Pacific >> Partnerships >> Collaborating Centers Donors Regional health initiatives Careers >> Contact us >> RCM 2022 >> Home / Health topics / Essential medicines Essential medicines Essential medicines in the Western Pacific Essential medicines are those that satisfy the priority health care needs of the population. (...) The increasing need for essential medicines due to the growing burden of diseases is stretching country pharmaceutical systems and budgets. (...) Technical links Fact sheets Prequalification of medicines by WHO Substandard and falsified medical products Universal health coverage (UHC) Data Essential medicines Priority health technologies Western Pacific Health Data Platform on Essential Medicines WHO resolutions Addressing the global shortage of, and access to, medicines and vaccines, Report by the Director-General (A71/12) WHO/Yoshi Shimizu © Credits 14.11 14.11 Public spending on medicines per person per year (2007), US$ in Lower income countries   WHO/Yoshi Shimizu © Credits 18 countries and territories 18 countries and territories have a National Medicines Policy in Place in the Western Pacific Region   WHO/Yoshi Shimizu © Credits 20.41 20.41 Public spending on medicines per person per year (2007), US$ in Middle-income countries   - Our work Strengthening health purchasing Tackling antimicrobial resistance Improving access to essential medicines Working towards universal health coverage Featured publications All → 31 January 2018 How pharmaceutical systems are organized in Asia and the Pacific Download Read More 24 August 2017 Towards access 2030: WHO essential medicines and health products strategic framework 2016-2030 Download Read More 14 June 2016 Universal health coverage : moving towards better health : action framework for the Western Pacific Region Download Read More News All → 13 October 2016 News release WHO Regional Committee for the Western Pacific notes progress on healthy newborn infants, antimicrobial resistance and essential medicines 16 April 2016 News release Asia Pacific countries vow to tackle antimicrobial resistance together 15 October 2015 News release La soixante-sixième session du Comité régional de l’OMS salue les progrès accomplis dans les domaines du vieillissement et de la santé, de la prévention et de la maîtrise des maladies non transmissibles, et du renforcement des systèmes de réglementation Multimedia 11 November 2021 Making medicines and the health workforce safer Related links Global programme on essential medicines and health products WHO Selection of essential medicines   Resources WHO Model Lists of Essential Medicines WHO Essential Medicines Teaching Resources PIEMEDS - Price Information Exchange for Medicines Sign in: Med Quality Assurance Related Health Topics All → Communicable diseases HIV Other Universal health coverage Health interventions Vaccines 1 (current) 2 3 Quick links Newsroom Emergencies Data Campaigns Publications About us Overview Programmes Country support Governance Partnerships Help Contact us Press Careers Email scams Privacy Legal Notice © 2022 WHO
Language:English
Score: 517241.16 - https://www.who.int/westernpac...h-topics/essential-medicines/1
Data Source: un
Mattingly © Credits Countries in WHO South-East Asia Region resolve to make essential medical products accessible, affordable to all 4 September 2018 News release India SEAR/PR/1670 New Delhi : Member countries of WHO South-East Asia Region today committed to make essential medicines, vaccines, diagnostics and medical devices affordable and accessible to all, both within the Region and beyond. (...) The Member countries committed to strengthen regulatory cooperation and collaboration to improve availability, quality and safety of essential medical products through the South-East Asia Regulatory Network (SEARN). (...) The Member countries committed to developing an essential medical products list, in particular essential diagnostics list, for improved patient care, affordability of quality tests, and greater capacity to diagnose diseases during outbreaks and strengthened capabilities of national laboratories.
Language:English
Score: 517029.8 - https://www.who.int/southeasta...s-accessible-affordable-to-all
Data Source: un
WHO | Supply chain: essential medicines Reproductive Health Essential Medicines Access Home Alt+0 Content Alt+2 Search Search RHEM Submit Advanced search Menu Home Prequalification Policy Procurement Supply chain Programme management Service delivery Supply chain: essential medicines Essential medicines library WHO Guidelines for the storage of essential medicines and other health commodities JSI Interagency list of medical devices for reproductive health, 2008 WHO, JSI, PATH, Population Action International, UNFPA, World Bank Medicines publications and documentation WHO You are here: Reproductive health essential medicines Supply chain and logistics management The RHEM Resource Portal has been made possible through the generous support of the Bill and Melinda Gates Foundation E-mail scams | WHO web site | Privacy © WHO 2022
Language:English
Score: 516883.06 - https://www.who.int/rhem/supplychain/essential_medicines/en/
Data Source: un
WHO | Databases Reproductive Health Essential Medicines Access Home Alt+0 Content Alt+2 Search Search RHEM Submit Advanced search Menu Home Prequalification Policy Procurement Supply chain Programme management Service delivery Databases Essential medicines library http://apps.who.int/emlib/ The WHO Essential Medicines Library is a web-based information service and provides access to the WHO Model List of Essential Medicines, Disease/Indication information, and the WHO Model Formulary. (...) WHO Model Formulary database (based on WHO Model List of Essential Medicines) http://apps.who.int/emlib/ModelList.aspx This edition of the Model Formulary is fully compatible with the 15th WHO Model List of Essential Medicines as recommended by the WHO Expert Committee on the Selection and Use of Essential Medicines at its meeting of March 2007. (...) You are here: Reproductive health essential medicines The RHEM Resource Portal has been made possible through the generous support of the Bill and Melinda Gates Foundation E-mail scams | WHO web site | Privacy © WHO 2022
Language:English
Score: 516823.05 - https://www.who.int/rhem/databases/en/
Data Source: un
Select language Select language English Western Pacific Home Health topics All health topics » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Popular topics >> COVID-19 Ageing Vaccines Universal Health Coverage Mental health Tobacco Antimicrobial resistance Climate change Featured topic >> Primary health care WHO/Yoshi Shimizu © Credits Our work Universal health coverage >> Healthy environments and populations >> Health security and emergencies >> Disease elimination and control >> Year of the Nurse and Midwife >> Resources >> Publications Library Data Regional data>> Regional COVID-19 dashboard Newsroom All news >> News releases Feature stories Commentaries Speeches Events Headlines >> Multimedia >> Photos Videos Infographics Featured story >> Emergencies Outbreaks and emergencies >> Coronavirus disease (COVID-19) Polio in Malaysia Polio outbreak in the Philippines Surveillance >> Influenza Avian influenza Dengue Emergency advice >> Pacific islands surveillance >> COVID-19 in the Region >> Getty images © Credits About us Overview >> How we work Where we work Programmes Country support Pacific Technical Support Governance >> Regional Director Regional Committee Working for Better Health in the Western Pacific >> Partnerships >> Collaborating Centers Donors Regional health initiatives Careers >> Contact us >> RCM 2022 >> Home / Health topics / Essential medicines Essential medicines Essential medicines in the Western Pacific Essential medicines are those that satisfy the priority health care needs of the population. (...) The increasing need for essential medicines due to the growing burden of diseases is stretching country pharmaceutical systems and budgets. (...) Technical links Fact sheets Prequalification of medicines by WHO Substandard and falsified medical products Universal health coverage (UHC) Data Essential medicines Priority health technologies Western Pacific Health Data Platform on Essential Medicines WHO resolutions Addressing the global shortage of, and access to, medicines and vaccines, Report by the Director-General (A71/12) WHO/Yoshi Shimizu © Credits 14.11 14.11 Public spending on medicines per person per year (2007), US$ in Lower income countries   WHO/Yoshi Shimizu © Credits 18 countries and territories 18 countries and territories have a National Medicines Policy in Place in the Western Pacific Region   WHO/Yoshi Shimizu © Credits 20.41 20.41 Public spending on medicines per person per year (2007), US$ in Middle-income countries   - Our work Featured publications All → News All → 13 October 2016 News release WHO Regional Committee for the Western Pacific notes progress on healthy newborn infants, antimicrobial resistance and essential medicines 16 April 2016 News release Asia Pacific countries vow to tackle antimicrobial resistance together 15 October 2015 News release La soixante-sixième session du Comité régional de l’OMS salue les progrès accomplis dans les domaines du vieillissement et de la santé, de la prévention et de la maîtrise des maladies non transmissibles, et du renforcement des systèmes de réglementation Multimedia Related links Global programme on essential medicines and health products WHO Selection of essential medicines   Resources WHO Model Lists of Essential Medicines WHO Essential Medicines Teaching Resources PIEMEDS - Price Information Exchange for Medicines Sign in: Med Quality Assurance Related Health Topics All → Diseases and conditions Malaria Other Sustainable Development Goals Diseases and conditions Tuberculosis 1 2 (current) 3 Quick links Newsroom Emergencies Data Campaigns Publications About us Overview Programmes Country support Governance Partnerships Help Contact us Press Careers Email scams Privacy Legal Notice © 2022 WHO
Language:English
Score: 516786.1 - https://www.who.int/westernpac...h-topics/essential-medicines/2
Data Source: un
Select language Select language English Western Pacific Home Health topics All health topics » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Popular topics >> COVID-19 Ageing Vaccines Universal Health Coverage Mental health Tobacco Antimicrobial resistance Climate change Featured topic >> Primary health care WHO/Yoshi Shimizu © Credits Our work Universal health coverage >> Healthy environments and populations >> Health security and emergencies >> Disease elimination and control >> Year of the Nurse and Midwife >> Resources >> Publications Library Data Regional data>> Regional COVID-19 dashboard Newsroom All news >> News releases Feature stories Commentaries Speeches Events Headlines >> Multimedia >> Photos Videos Infographics Featured story >> Emergencies Outbreaks and emergencies >> Coronavirus disease (COVID-19) Polio in Malaysia Polio outbreak in the Philippines Surveillance >> Influenza Avian influenza Dengue Emergency advice >> Pacific islands surveillance >> COVID-19 in the Region >> Getty images © Credits About us Overview >> How we work Where we work Programmes Country support Pacific Technical Support Governance >> Regional Director Regional Committee Working for Better Health in the Western Pacific >> Partnerships >> Collaborating Centers Donors Regional health initiatives Careers >> Contact us >> RCM 2022 >> Home / Health topics / Essential medicines Essential medicines Essential medicines in the Western Pacific Essential medicines are those that satisfy the priority health care needs of the population. (...) The increasing need for essential medicines due to the growing burden of diseases is stretching country pharmaceutical systems and budgets. (...) Technical links Fact sheets Prequalification of medicines by WHO Substandard and falsified medical products Universal health coverage (UHC) Data Essential medicines Priority health technologies Western Pacific Health Data Platform on Essential Medicines WHO resolutions Addressing the global shortage of, and access to, medicines and vaccines, Report by the Director-General (A71/12) WHO/Yoshi Shimizu © Credits 14.11 14.11 Public spending on medicines per person per year (2007), US$ in Lower income countries   WHO/Yoshi Shimizu © Credits 18 countries and territories 18 countries and territories have a National Medicines Policy in Place in the Western Pacific Region   WHO/Yoshi Shimizu © Credits 20.41 20.41 Public spending on medicines per person per year (2007), US$ in Middle-income countries   - Our work Featured publications All → News All → 13 October 2016 News release WHO Regional Committee for the Western Pacific notes progress on healthy newborn infants, antimicrobial resistance and essential medicines 16 April 2016 News release Asia Pacific countries vow to tackle antimicrobial resistance together 15 October 2015 News release La soixante-sixième session du Comité régional de l’OMS salue les progrès accomplis dans les domaines du vieillissement et de la santé, de la prévention et de la maîtrise des maladies non transmissibles, et du renforcement des systèmes de réglementation Multimedia Related links Global programme on essential medicines and health products WHO Selection of essential medicines   Resources WHO Model Lists of Essential Medicines WHO Essential Medicines Teaching Resources PIEMEDS - Price Information Exchange for Medicines Sign in: Med Quality Assurance Related Health Topics All → Health equity 1 2 3 (current) Quick links Newsroom Emergencies Data Campaigns Publications About us Overview Programmes Country support Governance Partnerships Help Contact us Press Careers Email scams Privacy Legal Notice © 2022 WHO
Language:English
Score: 516786.1 - https://www.who.int/westernpac...h-topics/essential-medicines/3
Data Source: un
. • 1 pending (ARV in MIC) • 2 rejected • 5 concerned non-HIV products Use of TRIPS flexibilities ‘01 – ’14 widespread 0 5 10 15 20 25 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Par 7 GU/CL 4/5 non HIV Learning from the past … … is mostly learning from HIV/AIDS Absence of pharmaceutical product patents in India Use of Doha • Compulsory licensing/ Government use • Paragraph 7 Doha (LDC extension) 2010 Illuminating the Future New Essential Medicines and Patents • Post TRIPS ‐medicines are subject to patenting more widely • For ARVs Medicines Patent Pool – no such mechanism exists  for other medicines • 2015 WHO EML update contains new, patented and high‐priced  essential medicines • Including biologics • Huge challenges for access to these essential medicines New essential medicines and patents Medicine Company (originator) Expiry date primary patent Tuberculosis bedaquiline Janssen 2023 delamanid Otsuka 2023 terizidone 2024 Hepatitis C sofosbuvir Gilead 2024 (‘28 prodrug) simeprevir Janssen 2026 daclatasvir Bristol-Myers Squibb 2027 ledipasvir Gilead 2030 ombitasvir Abbvie 2030 Cancer bendamustine Cephalon (US) 2026 imatinib Novartis 2014 (2018 second.) rituximab Roche (others) 2008 (‘19-’20 –’30 form.) trastuzumab Roche 2009 Price / cost of new essential medicines Medicine Originator price intro US Cost of production1 Tuberculosis bedaquiline $ 30,000 ( 6 month) - Hepatitis C Sofosbuvir (SOF) $ 84,000 (12 week) $68 -136 SOF+ledipasvir $ 95,000 (12 weeks) $ 193 simeprevir $ 66,360 (12 weeks) $130 - 270 daclatasvir $ 63,000 (12 weeks) $10 - 30 Cancer imatinib $ 30.000 - >$100,000 (1y) $ 119-159 rituximab trastuzumab $54,000 (1 year) $ 242 1. http://cid.oxfordjournals.org/content/early/2014/02/13/cid.ciu012.full (cost of production of HCV medicines) Hill A. etal.,Target prices for mass production of Tyrosine Kinase Inhibitors (TKIs) for global cancer treatment access - Presented at 18th ECCO - 40th ESMO European Cancer Congress, 27th September 2015, Vienna, Austria [abstract number: 1203] Thanks to A.Hill who Presented this at 18th ECCO - 40th ESMO European Cancer Congress, 27th September 2015, Vienna, Austria [abstract number: 1203] Imatinib – for treatment of Leukaemia (CML and ALL) Learning from the ancient past • WHO Essential Medicines policy firmly rooted in generic policies • Essential Medicines in some countries had special status with regards to patentability Action for Essential Medicines: some recommendations • The WHO designation “Essential Medicine” should have consequences • Action is required to make new essential medicines affordable and available • Today: Grant the LDC request for extension of Pharmaceutical waiver • Licensing of patents in case of patent barriers to affordable pricing  • Governments can do this through compulsory licensing /government use • Collaborative models  Essential Medicines Patent Pool • New rules for financing of R&D for missing essential medicines  innovation + access Thank you!
Language:English
Score: 516502.1 - https://www.wto.org/english/tr.../Ellen_T_Hoen_trilatsymp_e.pdf
Data Source: un
This came at the right time as there was a demand for essential drugs by facilities which had been faced with some shortages. (...) “As a health centre, we are grateful to have received the essential medicines and supplementary kits from UNICEF and its partners,” she said. (...) UNICEF/Zambia/2021/Siakachoma UNICEF and its partners Sida, FCDO, KfW and the World Bank have procured 4,074 health kits containing essential medicines which have been distributed to all ten provinces of Zambia to help maintain essential health services during the COVID-19 pandemic.
Language:English
Score: 516502.1 - https://www.unicef.org/zambia/...vital-during-covid-19-pandemic
Data Source: un